PROZAC WEEKLY
LOE ApproachingNDAORALCAPSULE, DELAYED REL PELLETS
Approved
Feb 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PROZAC WEEKLY is a delayed-release oral capsule formulation of fluoxetine, a selective serotonin reuptake inhibitor (SSRI) approved in 2001. It is indicated for depression and other psychiatric conditions where once-weekly dosing improves patient adherence. The mechanism involves inhibition of serotonin reuptake in the central nervous system.
LOE Approaching
Product is in late lifecycle stage with moderate competitive pressure (30), indicating a consolidating team focused on retention and cost management rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PROZAC WEEKLY offers experience in mature brand management, managed care negotiations, and generic competition defense—valuable skills but limited growth trajectory. This role suits professionals seeking stability and cost-management expertise rather than new product launches or innovation.
Brand ManagerField Sales Representative
Worked on PROZAC WEEKLY at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.